The Kislinger Laboratory is located at the Princess Margaret Cancer Research Tower of the Princess Margaret Cancer Centre, the largest oncology treatment and research facility in Canada. The major goal of our lab is to apply proteomics technologies to cancer and cardiovascular research. Our research interests include technology development, using the latest generation of mass spectrometry instrumentation, basic cell biology and translational cancer research.
A Genome Scale Screen for Mutants with Delayed Exit from Mitosis: Ire1-Independent Induction of Autophagy Integrates ER Homeostasis into Mitotic Lifespan.
PLoS Genet. 2015 Aug;11(8):e1005429
Multidimensional protein identification technology analysis highlights mitoxantrone-induced expression modulations in the primary prostate cancer cell proteome.
Proteomics Clin Appl. 2009 Mar;3(3):347-58
Semi-supervised Learning Predicts Approximately One Third of the Alternative Splicing Isoforms as Functional Proteins.
Cell Rep. 2015 Jul 1;
Mol Cancer Res. 2015 Mar 17;
Expansion of stem cells counteracts age-related mammary regression in compound Timp1/Timp3 null mice.
Nat Cell Biol. 2015 Feb 23;
Cancer Res. 2015 Jan 14;
Proteomics. 2014 Dec 24;
Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact.
Nat Commun. 2014;5:5469
Nat Rev Urol. 2014 Nov 18;
Senior Scientist, Princess Margaret Cancer Centre